View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Trastuzumab 6 / Docetaxel 70, Salivary Gland Tumor, Cycle 2+
Protocol-ID: 1698 V0.1 (Mini), TRAS6/DOCE70, salivary gland tumor, C2+Indication(s)
- Salivary Gland Tumor (HER2+); ICD-10 C08.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 16.01.2021